CLASS II Drug recall · Reported 22 May 2024 · FDA Enforcement Report

Gordofilm Wart Remover (salicylic acid 7% USP) recalled

Dercher Enterprises, Inc is recalling Gordofilm Wart Remover (salicylic acid 7% USP), distributed nationwide in the US. The recall was initiated on 12 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: F135, Exp. Date March 2025; F146, Exp. Date April , 2025; G103, Exp. Date January 2026; G194, Exp. Date September 2026
Quantity recalled5,247 glass jars

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0495-2024
FDA event ID
94355
Recalling firm
Dercher Enterprises, Inc, Upper Darby, PA
Classification
Class II
Status
Completed
Recall initiated
12 Apr 2024
FDA classified
13 May 2024
Reported
22 May 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

12 Apr 2024Recall initiated by company
13 May 2024Classified by FDA+31 days
22 May 2024Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP Deviations

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Gordofilm Wart Remover (salicylic acid 16.7% USP) packaged in 15 cc glass jars, Gordon Laboratories, Upper Darby PA 19082, NDC 10481-3009-01

Where it was distributed

Product was distributed nationwide within the United States

Nationwide

Questions about this recall

Is Gordofilm Wart Remover (salicylic acid 7% USP) recalled?

Yes. Dercher Enterprises, Inc recalled Gordofilm Wart Remover (salicylic acid 7% USP) on 12 Apr 2024. The recall is Class II and its status is Completed. Recall number D-0495-2024.

Why was it recalled?

cGMP Deviations

Which lots are affected?

Lot #: F135, Exp. Date March 2025; F146, Exp. Date April , 2025; G103, Exp. Date January 2026; G194, Exp. Date September 2026

Where was it sold?

Product was distributed nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dercher Enterprises, Inc

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIMonsel's (Ferric Subsulfate) Solution amber recalledDercher Enterprises, IncForeign MaterialNationwide